New Mexico Opens Medical Psilocybin Producer Permits
New Mexico’s Medical Psilocybin Program begins accepting producer permit applications, marking a critical step towards therapeutic access for qualifying patients.
Author: Tomas Lindqvist
-
-
UK Employers: Duty of Care for Medical Cannabis Patients
UK employers must apply existing duty of care and disability laws to medical cannabis patients, ensuring fair assessment and reasonable adjustments in…
-
Illinois Considers Outdoor Commercial Cannabis Cultivation
Illinois officials propose a rule change to allow outdoor commercial cannabis cultivation. This could significantly reduce costs and expand canopy for licensed…
-
Germany’s Medical Cannabis Reimbursement Chaos: Shifting Rules
Germany’s recent health insurance reform has thrown medical cannabis reimbursement into disarray, affecting patients and pharmacies alike. Learn about the shifting rules…
-
Curaleaf Bids for Aurora: Reshaping Europe’s Cannabis Market
Curaleaf’s unsolicited bid for Aurora Cannabis signals a major consolidation in the European medical cannabis market, highlighting strategic shifts and growth in…
-
California Cannabis Recall: Packaging Rules & Child Safety
California’s DCC issued a voluntary recall for a cannabis product. Packaging with a figurine violated rules by being attractive to children. Consumers…
-
UN Report: Global Cannabis Use Up 40%, Policy Shifts and Market Dynamics
UNODC report shows global cannabis use up 40% over 10 years, with a complex mix of policy reform and growing illicit market…
-
New York Law Allows Cannabis Sales at Farmers Markets
New York has enacted a new law permitting licensed cannabis sales at farmers markets and community events, aiming to bolster small growers…
-
UK Medical Cannabis Patients Face Stigma and Confidence Crisis
Medical cannabis patients in the UK face ongoing stigma and a crisis of confidence, impacting their daily lives and treatment adherence. Negative…